Alessandra Capital Management’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$743K Sell
30,384
-26,561
-47% -$739K 0.52% 52
2026
Q2
$1.95M Sell
56,945
-5,661
-9% -$171K 1.38% 18
2026
Q1
$1.49M Buy
62,606
+11,531
+23% +$320K 1.27% 23
2025
Q4
$1.42M Buy
+51,075
New +$1.3M 1.26% 22

Other funds holding BEAM

Alessandra Capital Management's BEAM Position: Q3 2026 in Review

Alessandra Capital Management reduced its Beam Therapeutics (BEAM) stake by 47% in Q3 2026, selling an estimated $739K and leaving 30,384 shares worth $743K. The position accounts for 0.52% of the portfolio, ranked #52.

Alessandra Capital Management first reported a position in BEAM in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.95M in Q2 2026. 264 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.

  • Alessandra Capital Management held 30,384 shares of Beam Therapeutics worth $743K as of Q3 2026.
  • Alessandra Capital Management sold 26,561 Beam Therapeutics shares in Q3 2026, an estimated $739K.
  • Beam Therapeutics made up 0.52% of Alessandra Capital Management's portfolio in Q3 2026, its #52 holding.
  • Alessandra Capital Management first reported a position in Beam Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Alessandra Capital Management's Beam Therapeutics position peaked at $1.95M in Q2 2026.
  • 264 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.

Based on Alessandra Capital Management's 13F filing for Q3 2026, filed 30 Oct 2026.